DEA Proposes Allowing Federally Certified Opioid Treatment Programs To Operate Mobile Units Without A Separate Registration
The Drug Enforcement Administration (DEA) recently proposed revising its regulations for federally certified opioid treatment programs (OTPs) to allow the programs to operate a mobile component without obtaining a separate registration. Such programs could dispense narcotic drugs in schedules II-V at a remote location for the purpose of maintenance or detoxification treatment. The proposed rule would consider the mobile program to be a “coincident” activity.
Specifically, for OTPs with mobile components, the DEA said it would waive the requirement of a …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.